research grade retatrutide 10mg Peptide (GLP-1/GIP/Glucagon Triple Agonist) Retatrutide – Power Peptides

Always consult Dr

While the first drug in this class, exenatide (Byetta), was approved by the FDA in 2005, more recent drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) outperform the older drugs in the class and other anti-obesity medications

Our team can help eligible patients understand available treatment options, medication instructions, pharmacy labeling, dose calculations, and provider-supervised weight loss care

Abdomen : Often preferred for its ease of access and minimal discomfort

The lawsuits allege that the drug, which mimics the GLP-1 hormone in the body that aids in insulin secretion, causes severe side effects, including gastroparesis and pancreatic cancer